IPO and SecondariesIPO BoutiqueYour Reliable IPO and Secondaries Advisory
<< Return Home

Subscribe Now

  IPO Boutique Blog
  FREE IPO Newsletter
IPO Central
  IPO Calendar
  IPO Pipeline
  Track Record
  2017 IPOs
    IPO Pricings
    Industry Breakdown
  2016 IPOs
  2015 IPOs
  2014 IPOs
  2013 IPOs
  2012 IPOs
  Sample IPO
  Rating Scale
  IPO Primer
  Current Week
  Track Record
  2017 Secondaries
  2016 Secondaries
  2015 Secondaries
  2014 Secondaries
  2013 Secondaries
  2012 Secondaries
  Secondaries Primer
International publications
quoting IPO Boutique
founder Scott Sweet
General Info
  About Us
  Contact Us
  Site Map
SubscriptionsTrack RecordIPO CalendarPipelineFree Sample IPOBlogTestimonialsContact UsAbout UsSite Map

IPO's by Industry: Health Care

Browse Industries: Business Services | Consumer | Communications | Energy | Financial | Industrial | Materials | Technology | Transportation

AAC Holdings, Inc.AACPriced at $15.005 million10/2/2014William Blair, Raymond James
AC Immune SAACIU$11.00-$13.006 million9/23/2016Credit Suisse, Jefferies, Leerink Partners
Accelerated PharmaACCP$4.00-$6.002.4 million0/0/0Rodman & Renshaw
Acelity HoldingsTBDWithdrawnTBD0/0/0J.P. Morgan, Goldman Sachs & Co., BofA Merrill Lynch
Achaogen, Inc.AKAOPriced at $12.006 million3/12/2014Credit Suisse, Cowen & Co.
Aclaris TherapeuticsACRS$14.00-$16.005 million10/7/2015Jefferies, Citigroup
Adamas PharmaceuticalsADMSPriced at $16.003 million4/10/2014Credit Suisse, Piper Jaffray
AdaptImmune TherapeuticsADAPPriced at $17.0011.25 million5/6/2015BofA Merrill Lynch, Cowen & Co., Leerink Partners
Adeptus HealthADPTPriced at $22.004.9 million6/25/2014Deutsche Bank Securities, Goldman Sachs & Co., Evercore, Morgan Stanley
ADMA BiologicsADMAPriced at $8.503.35 million10/17/2013Oppenheimer & Co., BMO Capital Markets
Aduro BiotechADROPriced at $17.007 million4/15/2015BofA Merrill Lynch, Leerink Partners
Advanced Accelerator Applications S.A.AAAP$15.00-$17.004.7 million11/11/2015Citigroup, Jefferies
Advanced Inhalation Therapies, Ltd.AITPU$15.00-$15.00333,3330/0/0Joseph Gunnar & Co.
Aeglea Therapeutics, Inc.AGLE$16.00-$18.005 million4/7/2016UBS Investment Bank, BMO Capital Markets, Wells Fargo Securities
Aerie PharmaceuticalsAERIPriced at $10.006.72 million10/25/2013RBC Capital Markets, Stifel Nicolaus Weisel
Affimed Therapeutics B.V.AFMDPriced at $7.008 million9/12/2014Jefferies, Leerink Partners BMO Capital Markets
Agile Therapeutics, Inc.AGRXPriced at $6.009.2 million5/23/2014RBC Capital Markets, William Blair
Agios PharmaceuticalsAGIO7/24/2014J.P. Morgan, Goldman Sachs
Aimmune Therapeutics, Inc.AIMT$14.00-$16.0010 million8/6/2015BofA Merrill Lynch, Credit Suisse, Piper Jaffray
Akcea Therapeutics, Inc.AKCATBDTBD0/0/0Cowen and Company, Stifel, Wells Fargo Securities
Akebia TherapeuticsAKBAPriced at $17.005.88 million3/20/2014Morgan Stanley, Credit Suisse
Alder BiopharmaceuticalsALDR$13.00-$15.007.15 million5/8/2014Credit Suisse, Leerink Partners.
Ambit Biosciences CorporationAMBIPriced at $8.008.1 million5/16/2013 Citigroup, Leerink Swann
Amedica CorporationAMDAPriced at $5.753.5 million2/13/2014JMP Securities
American Renal Associates HoldingsARA$20.00-$23.007.5 million4/21/2016BofA Merrill Lynch, Barclays, Goldman Sachs & Co., Wells Fargo Securities, SunTrust Robinson Humphrey
Amphastar PharmaceuticalsAMPHPriced at $7.008 million6/25/2014Jefferies, BMO Capital Markets, Piper Jaffray
AnaptysBio, Inc.ANAB$14.00-$16.005 million1/26/2017Credit Suisse, Stifel
Apellis PharmaceuticalsAPLSTBDTBD0/0/0Citigroup, Barclays, Leerink Partners
Applied Genetic Technologies CorpAGTCPriced at $12.004.2 million3/27/2014BMO Capital Markets, Wedbush PacGrow Life Science
Aquinox Pharmaceuticals, Inc.AQXPPriced at $11.004.2 million3/7/2014Jefferies, Cowen & Co.
Arcadia Biosciences, Inc.RKDAPriced at $8.008.2 million 5/15/2015Credit Suisse, J.P. Morgan, Piper Jaffray
Ardelyx Inc.,ARDXPriced at $14.004.3 million6/19/2014Citigroup, Leerink Partners
Argos TherapeuticsARGSPriced at $8.005.63 million2/7/2014Piper Jaffray, Stifel, JMP Securities
Ascendis Pharma A/SASNDPriced at $18.006 million1/28/2015BofA Merrill Lynch, Leerink Partners, Wells Fargo Securities
Atara Biotherapeutics, Inc.ATRAPriced at $11.005 million10/16/2014Goldman Sachs & Co., Citigroup
aTyr PharmaLIFEPriced at $14.005.4 million5/7/2015J.P. Morgan, Citigroup
Audentes Therapeutics, Inc.BOLD$14.00-$16.005 million7/20/2016BofA Merrill Lynch, Cowen & Co., Piper Jaffray
Auris Medical Holding AGEARSPriced at $6.009.4 million8/6/2014Jefferies, Leerink Partners
Auspex PharmaceuticalsASPXPriced at $12.007 million2/5/2014Stifel, BMO Capital Markets
Avalanche Biotechnologies, Inc.AAVL$13.00-$15.005.4 million7/31/2014Jefferies, Cowen & Co., Piper Jaffray
AveXis, Inc.AVXS$19.00-$21.004.75 million2/11/2016Goldman Sachs & Co., Jefferies
Avinger, Inc.AVGRPriced at $13.005 million1/30/2015Canaccord Genuity, Cowen & Co.
Axovant Sciences, Ltd.AXON$13.00-$15.0021 million6/11/2015Jefferies, Evercore ISI, RBC Capital Markets
Axsome TherapeuticsAXSM$11.00-$13.005.6 million11/19/2015Ladenburg Thalmann
AzurRx, Inc.AZRX$6.00-$8.00960 thousand10/11/2016WallachBeth Capital, Network 1 Financial
BeiGene, Ltd.BGNE$15.00-$17.006.6 million2/3/2016Goldman Sachs & Co., Morgan Stanley, Cowen & Co.
Bellerophon TherapeuticsBLPH$14.00-$16.004 million2/13/2015Leerink Partners, Cowen & Co.
Bellicum PharmaceuticalsBLCMPriced at $19.007.35 million12/18/2014Jefferies, Citigroup, Piper Jaffray
BeyondSpring Inc.BYSI$20.00-$22.00174K3/9/2017Rodman & Renshaw
Bind Therapeutics, Inc.BINDPriced at $15.004.7 million9/20/2013Credit Suisse, Cowen & Co.
Bio Blast Pharma Ltd.ORPNPriced at $11.003.2 million7/31/2014Oppenheimer & Co., Roth Capital Partners
Bioceres S.A.BIOXTBDTBD0/0/0Piper Jaffray, Itau BBA
Biohaven Pharmaceutical Holding Company Ltd.BHVN$14.00-$16.008.33 million5/4/2017Morgan Stanley, Piper Jaffray, Barclays
Bioventus Inc.BIOV$16.00-$18.008.82 million7/29/2016J.P. Morgan, Piper Jaffray
Blueprint Medicines CorporationBPMCPriced at $18.008.15 million4/30/2015Goldman Sachs & Co., Cowen & Co.
Calithera BiosciencesCALAPriced at $10.008 million10/2/2014Citigroup, Leerink Partners
Cancer GeneticsCGIXPriced at $10.00600 Thousand4/5/2013Aegis Capital Corp, Feltl & Co.
Cancer Prevention Pharmaceuticals CPPWithdrawn1.25 million0/0/0Aegis Capital
Capnia, Inc.CAPNPriced at $6.501.65 million11/13/2014Maxim Group LLC
Cara TherapeuticsCARAPriced at $11.005 million1/31/2014Stifel, Piper Jaffray
Carbylan TherapeuticsCBYLPriced at $5.0013 million4/9/2015Leerink Partners
CareDx Inc.,CDNAPriced at $10.004 million7/17/2014Piper Jaffray, Leerink Partners
Catabasis PharmaceuticalsCATB$13.00-$15.005 million6/25/2015Citigroup, Cowen & Co.
Catalent, Inc.CTLTPriced at $20.5042.5 million7/31/2014Morgan Stanley, J.P. Morgan
Cellular Dynamics InternationalICELPriced at $12.003.9 million7/25/2013J.P. Morgan
Cempra HoldingsCEMP$11.00-$13.006 million2/3/2012Stifel Nicolaus Weisel, Leerink Swann, Cowen and Company
Cerecor, Inc.CERC$6.00-$7.004 million10/15/2015Maxim Group LLC
Cerulean PharmaCERUPriced at $7.008.5 million4/10/2014Leerink Partners
Check-Cap Ltd.CHEKUPriced at $6.002 million2/19/2015Chardan Capital Markets, LLC, Maxim Group LLC
Chiasma, Inc.CHMA$13.00-$15.006.36 million7/16/2015Barclays, Cowen & Co.
Cidara Therapeutics CDTXPriced at $16.004.8 million4/15/2015Jefferies, Leerink Partners
Civitas Solutions, Inc.CIVIPriced at $17.0011.7 million9/17/2014Barclays, Jefferies, BofA Merrill Lynch, UBS Investment Bank
Clearside BiomedicalCLSD$7.00-$7.007.2 million6/2/2016Cowen & Co., Stifel
Coherus BioSciences, Inc.CHRSPriced at $13.506.3 million11/6/2014J.P. Morgan, Credit Suisse
Collegium PharmaceuticalCOLLPriced at $12.005.8 million5/7/2015Jefferies, Piper Jaffray
Colucid PharmaceuticalsCLCDPriced at $10.005.5 million5/6/2015Piper Jaffray, Stifel
Community Healthcare TrustCHCT$19.00-$21.006.25 million5/21/2015Sandler O' Neill + Partners LP, Evercore ISI, SunTrust Robinson Humphrey
Conatus PharmaceuticalsCNATPriced at $11.006 million7/25/2013Stifel Nicolaus Weisel, Piper Jaffray
Concert Pharmaceuticals, Inc.CNCEPriced at $14.006 million2/13/2014UBS Investment Bank, Wells Fargo Securities
ConforMIS, Inc.CFMS$14.00-$16.009 million7/1/2015J.P. Morgan, Deutsche Bank Securities
Corium International, Inc.CORIPriced at $8.006.5 million4/3/2014Jefferies, Leerink Partners
Corvus PharmaceuticalsCRVS$15.00-$17.004.7 million3/23/2016Credit Suisse, Cowen & Co., Guggenheim Securities
CRISPR TherapeuticsCRSP$15.00-$17.004 million10/19/2016Citigroup, Piper Jaffray, Barclays
CytomX TherapeuticsCTMX$14.00-$16.006.7 million10/8/2015BofA Merrill Lynch, Jefferies, Cowen & Co.
Dermira, Inc.DERMPriced at $16.007.8 million10/3/2014Citigroup, Leerink Partners
Dicerna Pharmaceuticals, Inc.DRNAPriced at $15.006 million1/30/2014Jefferies, Leerink Swann, Stifel
Dimension TherapeuticsDMTX$14.00-$16.005.5 million10/22/2015Goldman Sachs & Co., Citigroup, Wells Fargo Securities
Dipexium Pharmaceuticals, LLCDPRXPriced at $12.002.75 million3/13/2014Oppenheimer & Co., Feltl & Co.
Diplomat PharmacyDPLOPriced at $13.0013.33 million10/10/2014Credit Suisse, Morgan Stanley
Eagle PharmaceuticalsEGRXPriced at $15.003.33 million2/12/2014Piper Jaffray, William Blair
Edge TherapeuticsEDGE$14.00-$16.007.3 million10/1/2015Leerink Partners, Credit Suisse
Editas Medicine, Inc.EDIT$16.00-$18.005.9 million2/3/2016Morgan Stanley, J.P. Morgan
EgaletEGLTPriced at $12.004.2 million2/6/2014Stifel, JMP Securities
Eleven BiotherapeuticsEBIOPriced at $10.005 million2/6/2014Citigroup, Cowen & Co., Leerink Swann
Ellipse Technologies, Inc.MGECTBDTBD0/0/0Piper Jaffray, William Blair, Canaccord Genuity
Enanta PharmaceuticalsENTAPriced at $14.004 million3/21/2013J.P. Morgan, Credit Suisse
EndoChoice HoldingsGI$15.00-$17.006.35 million6/5/2015J.P. Morgan, BofA Merrill Lynch
Endostim, Inc.STIMWithdrawn3.2 million0/0/0Wedbush PacGrow Life Sciences
Endra Life SciencesNDRA$5.00-$5.501.4 million4/27/2017Dougherty & Company, Dawson James
Entellus MedicalENTLPriced at $17.004.6 million1/29/2015BofA Merrill Lynch, Piper Jaffray
Epocrates, Inc.EPOC0/0/0J.P. Morgan
Evoke PharmaEVOKPriced at $12.002.1 million9/25/2013Aegis Capital Corp
Evolent HealthEVH$14.00-$16.0011.5 million6/5/2015J.P. Morgan, Goldman Sachs & Co.
Exagen Diagnostics, Inc.EXDXTBDTBD0/0/0Leerink Partners, Baird
Fate Therapeutics, Inc.FATEPriced at $6.006.7 million10/1/2013Cowen & Co., BMO Capital Markets
FibroGen, Inc.FGENPriced at $18.008.1 million11/14/2014Goldman Sachs & Co., Citigroup, Leerink Partners
Five Prime TherapeuticsFPRX$12.00-$14.002.8 million9/18/2013Jefferies, BMO Capital Markets, Wells Fargo Securities
Flex PharmaFLKSPriced at $16.005.4 million1/29/2015Jefferies, Piper Jaffray
Flexion Therapeutics, Inc.FLXNPriced at $13.005 million2/12/2014BMO Capital Markets, Wells Fargo Securities
Foamix PharmaceuticalsFOMXPriced at $6.006.7 million9/18/2014Barclays, Cowen and Company
Forward PharmaFWPPriced at $21.0010.5 million10/15/2014Leerink Partners, Jefferies, RBC Capital Markets
Foundation MedicineFMIPrice at $18.005.89 million9/25/2013Goldman Sachs, J.P. Morgan
Fulgent Genetics, Inc.FLGT$12.00-$14.004.2 million9/29/2016Credit Suisse, Piper Jaffray, Raymond James
G1 Therapeutics, Inc.GTHXTBDTBD0/0/0J.P. Morgan, Cowen and Company
Gemphire Therapeutics GEMP$11.00-$13.003 million8/5/2016Jefferies, RBC Capital Markets
GenSight Biologics S.A.GNSTWithdrawn11/6/2015Leerink Partners, Evercore ISI, Canaccord Genuity
Glaukos CorporationGKOS$13.00-$15.006 million6/25/2015J.P. Morgan, BofA Merrill Lynch, Goldman Sachs & Co.
Global Blood TherapeuticsGBT$16.00-$18.006 million8/12/2015Morgan Stanley, Goldman Sachs & Co.
Globus MedicalGMEDPriced at $12.008.33 million8/3/2012BofA Merrill Lynch, Goldman Sachs, Piper Jaffray
GlycoMimeticsGLYCPriced at $8.007.0 million1/10/2014Jefferies, Barclays
Heat BiologicsHTBXPriced at $10.002.5 million7/24/2013Aegis Capital Corp
Histogenics CorporationHSGXPriced at $11.005.91 million12/3/2014Cowen & Co., Needham & Co., Canaccord Genuity
HTG Molecular DiagnosticsHTGMPriced at $14.003.6 million5/6/2015Leerink Partners
IASIS Healthcare CorporationIASWithdrawnTBD0/0/0BofA Merrill Lynch, Barclays, J.P. Morgan
iKang Healthcare Group, Inc.KANGPriced at $14.0010.9 million4/9/2014BofA Merrill Lynch, UBS Investment Bank
Immune Design CorpIMDZPriced at $12.005 million7/24/2014Jefferies, Leerink Partners, Wells Fargo Securities
INC Research Holdings, Inc.INCRPriced at $18.508.1 million11/7/2014Goldman Sachs, Credit Suisse
Innocoll GmbHINNLPriced at $9.006.3 million7/25/2014Piper Jaffray, Stifel
Inogen, Inc.INGNPriced at $16.004.4 million2/14/2014J.P. Morgan
Inotek Pharmaceuticals CorporationITEKPriced at $6.006.67 million2/18/2015Cowen & Co., Piper Jaffray
Intellia TherapeuticsNTLAPriced at $18.006 million5/6/2016Credit Suisse, Jefferies, Leerink Partners
Intersect ENT, Inc.XENTPriced at $11.005 milion7/24/2014J.P. Morgan, Piper Jaffray
IntrexonXONPriced at $16.0010 million8/8/2013J.P. Morgan, Barclays Capital
inVentiv Group HoldingsINVTBDTBD0/0/0Credit Suisse, Morgan Stanley, Goldman Sachs & Co., Jefferies
Invitae CorporationNVTAPriced at $16.006.35 million2/12/2015J.P. Morgan
Invuity, Inc.IVTY$12.00-$12.004 million6/15/2015Piper Jaffray, Leerink Partners, Stifel
iRadimed Inc.IRMDPriced at $6.252.02 million7/16/2014Roth Capital Partners
Jaguar Animal HealthJAGXPriced at $7.002.86 million5/13/2015Aegis Capital Corp
Jounce TherapeuticsJNCE$13.00-$15.006.365 million1/27/2017J.P. Morgan, Cowen and Company
Juno TherapeuticsJUNOPriced at $24.0011.02 million12/19/2014Morgan Stanley, J.P. Morgan, Goldman Sachs & Co.
K2M Group Holdings, Inc.KTWOPriced at $15.008.83 million5/8/2014Piper Jaffray, Barclays, Wells Fargo Securities
Kadmon Holdings, LLCKDMN$16.00-$20.006.25 million7/27/2016Citigroup, Jefferies
Karyopharm TherapeuticsKPTI$14.00-$16.005.7 million11/6/2013BofA Merrill Lynch, J.P. Morgan, Leerink Partners
KemPharm, Inc.KMPHPriced at $11.005.09 million4/16/2015Cowen & Co., RBC Capital Markets
Kite Pharma, Inc.,KITEPriced at $17.007.5 million6/20/2014Jefferies, Credit Suisse, Cowen and Co.
Lantheus HoldingsLNTH$8.50-$10.5010.83 million6/25/2015Credit Suisse, Jefferies, RBC Capital Markets, Wells Fargo Securities
Liposcience, Inc.LPDXPriced at $9.005 million1/25/2013Barclays Capital, UBS Investment Bank, Piper Jaffray
Loxo Oncology, Inc.LOXOPriced at $13.005.3 million8/1/2014Cowen & Co., Stifel
Lumenis Ltd.LMNSPriced at $12.006.25 million2/27/2014Goldman Sachs, Credit Suisse, Jefferies
Macrocure Ltd.MCURPriced at $10.005.4 million7/31/2014Credit Suisse, Jefferies
Mapi - Pharma Ltd.MAPI$15.00-$17.003.1 million0/0/0JMP Securities
Marinus PharmaceuticalsMRNSPriced at $8.005.62 million7/31/2014Stifel, JMP Securities
Mediwound Ltd.MDWDPriced at $14.005 million3/20/2014Credit Suisse, Jefferies, BMO Capital Markets
MedPace HoldingsMEDP$20.00-$23.007 million8/11/2016Jefferies, Credit Suisse, UBS Investment Bank, Wells Fargo Securities
Merus B.V.MRUS$14.00-$16.005.5 million5/19/2016Citigroup, Jefferies
Minerva NeurosciencesNERVPriced at $6.005.5 million7/1/2014Jefferies
Mirna TherapeuticsMIRN$13.00-$15.006.25 million10/1/2015Citigroup, Leerink Partners
Moleculin Biotech, Inc.MBRX$5.00-$6.001.54 million6/2/2016Bonwick Capital Partners LLC, Network 1 Financial Securities
MyoKardia, Inc.MYOK$15.00-$17.005.4 million10/29/2015Credit Suisse, Cowen & Co.
Myovant Sciences, Ltd.MYOV$12.00-$15.0014.5 million10/27/2016Citigroup, Cowen and Company, Evercore ISI, Barclays
Nabriva Therapeutics AGNBRV$10.50-$10.509 million9/18/2015Leerink Partners, RBC Capital Markets
Nant HealthNH$12.50-$15.506.5 million6/2/2016Jefferies, Cowen & Co.
NantKwestNK$20.00-$23.008.3 million7/28/2015BofA Merrill Lynch, Citigroup, Jefferies, Piper Jaffray
Natera, Inc.NTRA$15.00-$17.0010 million7/2/2015Morgan Stanley, Cowen & Co., Piper Jaffray
Neos TherapeuticsNEOS$14.00-$16.004.8 million7/23/2015UBS Investment Bank, BMO Capital Markets, RBC Capital Markets
Neothetics, Inc.NEOTPriced at $14.004.65 million11/20/2014Piper Jaffray, Guggenheim Securities
Neuroderm, Ltd.NDRMPriced at $10.004.5 million11/14/2014Jefferies, Cowen & Co.
NevroNVROPriced at $18.007 million11/6/2014J.P. Morgan, Morgan Stanley
Nexvet Biopharma plcNVETPriced at $10.004 million2/5/2015BofA Merrill Lynch, Cowen & Co.
Nivalis TherapeuticsNVLS$13.00-$15.005.5 million6/17/2015Cowen & Co., Stifel
Novan, Inc.NOVN$11.00-$13.004.1 million9/21/2016Piper Jaffray
NovoCure LimitedNVCR$26.00-$29.007.5 million10/2/2015J.P. Morgan, Deutsche Bank Securities, Evercore ISI
Obalon TherapeuticsOBLN$14.00-$16.005 million10/6/2016UBS Investment Bank, Canaccord Genuity, Stifel
ObsEva SAOBSV$14.00-$16.006.45 million1/26/2017Credit Suisse, Jefferies, Leerink Partners
Ocular TherapeutixOCULPriced at $13.005 million7/25/2014Morgan Stanley, Cowen & Co., RBC Capital Markets
Omthera PharmaceuticalsOMTHPriced at $8.008 million4/11/2013BofA Merrill Lynch, Barclays Capital, Leerink Swann
Oncobiologics, Inc.ONS$6.00-$6.005.8 million5/13/2016Jefferies, Barclays
OncoMed PharmaceuticalsOMEDPriced at $17.004.8 million7/18/2013Jefferies, Leerink Swann
Onconova TherapeuticsONTXPriced at $15.005.2 million7/25/2013 Citigroup, Leerink Swann
Opgen, Inc.OPGNPriced at $6.002.85 million5/5/2015Maxim Group LLC
OrthoPediatrics Corp.KIDSTBDTBD0/0/0Piper Jaffray, Stifel
Otonomy, Inc.OTICPriced at $16.006.25 million8/13/2014J.P. Morgan, BofA Merrill Lynch
Ovid Therapeutics Inc.OVIDTBDTBD0/0/0Citigroup, Cowen and Company
Oxford Immunotec Global PLCOXFDPriced at $12.005.36 million11/22/2013J.P. Morgan, Piper Jaffray
Parnell Pharmaceutical Holdings LtdPARN$10.00-$10.005 million6/18/2014Jefferies, Piper Jaffray
Patheon N.V.PTHN$19.00-$22.0029.76 million7/21/2016J.P. Morgan, Morgan Stanley, Jefferies, UBS Investment Bank,Credit Suisse, Evercore ISI, Wells Fargo Securities
Penumbra, Inc.PEN$25.00-$28.004 million9/18/2015J.P. Morgan, BofA Merrill Lynch
Pfenex, Inc.PFNXPriced at $6.008.33 million7/24/2014William Blair, JMP Securities
PhaseRx, Inc.PZRX$5.00-$7.003.7 million5/18/2016Laidlaw & Co., Roth Capital Partners
Phibro Animal Health CorporationPAHCPriced at $15.0012.745 million4/11/2014BofA Merrill Lynch, Morgan Stanley, Barclays
PLX PharmaPLXP$17.00-$19.003.8 million0/0/0Raymond James, Maxim Group LLC
PRA Health Sciences, Inc.PRAHPriced at $18.0016.98 million11/13/2014Jefferies, Citigroup, KKR, UBS Investment Bank, Credit Suisse, Wells Fargo Securities
Presbia PLCLENSPriced at $10.004.2 million1/29/2015Jefferies
Press Ganey HoldingsPGND$22.00-$24.008.9 million5/21/2015Barclays, Goldman Sachs & Co., William Blair, Wells Fargo Securities
ProNAi TherapeuticsDNAI$14.00-$16.008.1 million7/16/2015Jefferies, BofA Merrill Lynch
Proqr Therapeutics B.V.PRQRPriced at $13.007.5 million9/18/2014Leerink Partners, Deutsche Bank Securities
Prosensa Holding B.V.RNAPriced at $13.006 million6/28/2013J.P. Morgan, Citigroup, Leerink Swann
Protagonist TherapeuticsPTGX$12.00-$12.007.5 million8/11/2016Leerink Partners, Barclays, BMO Capital Markets
Proteon Therapeutics, Inc.PRTOPriced at $10.006.1 million10/22/2014Stifel, JMP Securities
Proteostasis TherapeuticsPTI$12.00-$14.006.25 million2/11/2016Leerink Partners, RBC Capital Markets
Pulse BiosciencesPLSE$4.00-$4.005 million5/18/2016MDB Capital Group LLC, Feltl and Company
Quotient LimitedQTNTUPriced at $8.005 million4/25/2014UBS Investment Bank, Baird, Cowen & Co.
RA PharmaceuticalsRARX$12.00-$14.007.05 million10/26/2016Credit Suisse, Jefferies, BMO Capital Markets
Radius HealthRDUSPriced at $8.006.5 million6/6/2014Jefferies, Cowen & Co.
Reata PharmaceuticalsRETA$14.00-$16.005.5 million5/26/2016Citigroup, Cowen & Co., Piper Jaffray
REGENXBIO, Inc.RGNX$17.00-$19.006.3 million9/17/2015Morgan Stanley, BofA Merrill Lynch, Piper Jaffray
Revance Therapeutics, Inc.RVNCPriced at $16.006 million2/6/2014Cowen & Co., Piper Jaffray
ReWalk Robotics Ltd.RWLKPriced at $12.003 million9/12/2014Barclays, Jefferies
Ritter PharmaceuticalsRTTR$5.00-$5.004 million6/24/2015Aegis Capital Corp, Chardan Capital Markets
Roka BiosciencesROKAPriced at $12.005 million7/17/2014BofA Merrill Lynch, Leerink Partners
Sage TherapeuticsSAGEPriced at $18.005 million7/18/2014J.P. Morgan, Goldman Sachs & Co.
Sancilio PharmaceuticalsSPCIWithdrawnTBD0/0/0UBS Investment Bank, Piper Jaffray
SCYNEXIS, Inc.SCYX$10.00-$10.006.2 million5/2/2014RBC Capital Markets, Canaccord Genuity
Second Sight Medical ProductsEYESPriced at $9.003.5 million11/19/2014MDB Capital Group LLC
Selecta BiosciencesSELB$14.00-$16.005 Million6/22/2016UBS Investment Bank, Stifel
SenesTech, Inc.SNES$12.00-$14.001.875 million12/8/2016Roth Capital Partners
Sensus HealthcareSRTS$6.25-$6.252 million6/3/2016Northland Capital Markets, Neidiger Tucker Bruner Inc
Seres TherapeuticsMCRB$15.00-$17.007.43 million6/26/2015Goldman Sachs & Co., BofA Merrill Lynch
Sientra, Inc.SIENPriced at $15.005 million10/29/2014Piper Jaffray, Stifel
Spark TherapeuticsONCEPriced at $23.007 million1/30/2015J.P. Morgan, Credit Suisse
Spring Bank PharmaceuticalsSBPH$12.00-$14.00920 Thousand5/6/2016Dawson James Securities
SteadyMed Ltd.STDYPriced at $8.504.7 million3/20/2015Wells Fargo Securities, RBC Capital Markets
Stemline TherapeuticsSTMLPriced at $10.003.3 million1/29/2013Aegis Capital Corp
Surgery Partners, Inc.SGRY$23.00-$26.0014.3 million10/1/2015BofA Merrill Lynch, Goldman Sachs & Co., Jefferies
Surgical Care AffiliatesSCAIPriced at $24.009.8 million10/30/2013J.P. Morgan, Citigroup
SurgiQuest, Inc.TBDWithdrawnTBD0/0/0Piper Jaffray, Stifel, Canaccord Genuity
Syndax Pharmaceuticals, Inc.SNDX$14.00-$16.004.4 million3/3/2016Morgan Stanley, Citigroup
Syros PharmaceuticalsSYRS$14.00-$16.004 million6/30/2016Cowen & Co., Piper Jaffray
T2 Biosystems, Inc.TTOOPriced at $11.005.2 million8/7/2014Goldman Sachs & Co., Morgan Stanley
Tabula Rasa HealthCareTRHC$13.00-$15.004.3 million9/29/2016Wells Fargo Securities, UBS Investment Bank, Piper Jaffray
Tactile Systems TechnologyTCMD$14.00-$16.004 million7/28/2016Piper Jaffray, William Blair, Canaccord Genuity
Tandem Diabetes CareTNDMPriced at $15.008.0 million11/14/2013BofA Merrill Lynch, Piper Jaffray
Teladoc, Inc.TDOC$15.00-$17.008.25 million7/1/2015J.P. Morgan, Deutsche Bank Securities
TesaroTSRO$12.00-$15.006.0 million6/28/2014Citigroup, Morgan Stanley, Leerink Swann
TetraLogic PharmaceuticalsTLOGPriced at $7.007.2 million12/12/2013Oppenheimer & Co., Guggenheim Securities, Needham & Co.
Thar Pharmaceuticals, Inc.THARTBDTBD0/0/0SunTrust Robinson Humphrey
The Joint Corp.JYNTPriced at $6.503 million11/11/2014Roth Capital Partners, Feltl and Company
Tocagen, Inc.TOCA$10.00-$12.008.5 million4/13/2017Leerink Partners, Evercore ISI, Stifel
Tokai Pharmaceuticals, Inc.TKAIPriced at $15.006.48 miillion9/17/2014BMO Capital Markets, Stifel, William Blair
Tracon Pharmaceutical TCONPriced at $10.003.6 million1/30/2015Wells Fargo Securities, Stifel
TranzymeTZYM$4.00-$4.0013.5 million4/4/2011Citigroup
TrevenaTRVNPriced at $7.009.3 million1/31/2014Barclays, Jefferies
Trivascular Technologies, Inc.TRIVPriced at $12.006.5 million4/16/2014J.P. Morgan, Credit Suisse
Trupanion Inc.TRUPPriced at $10.007.1 million7/18/2014RBC Capital Markets, Barclays, Stifel
Ultragenyx PharmaceuticalRAREPriced at $21.005.8 million1/31/2014J.P. Morgan, Morgan Stanley
uniQure B.V.QUREPriced at $17.005.4 million2/5/2014Jefferies, Leerink Swann, Piper Jaffray
UroGen Pharma Ltd.URGN$12.00-$14.003.46 milliion5/4/2017Jefferies, Cowen and Company
Vanguard Health Systems, Inc.VHSPriced at $18.0025 million6/22/2011BofA Merrill Lynch, Barclays Capital, Citigroup, Deutsche Bank Securities, J.P. Morgan
Vascular Biogenics, Ltd.VBLTPriced at $6.006.66 million10/1/2014Deutsche Bank Securities
Veracyte, Inc.VCYTPriced at $13.005 million10/30/2013Morgan Stanley, Leerink Swann
Verastem, Inc.VSTMLast trade $16.922.9 million7/17/2013Jefferies, Leerink Swann
Versartis, Inc.VSARPriced at $21.006 million3/21/2014Morgan Stanley, Citigroup
Viamet Pharmaceuticals Holdings, LLCVMET$14.00-$16.005.7 mill0/0/0Morgan Stanley, Goldman Sachs & Co.
Viking Therapeutics, Inc.VKTXPriced at $8.003 million4/29/2015Laidlaw & Company (UK) Ltd.
Visterra, Inc.VIST$12.00-$14.003.9 million0/0/0Leerink Partners, Stifel
Vitae Pharmaceuticals, Inc.VTAEPriced at $8.006.875 million9/24/2014Stifel, BMO Capital Markets
Vital TherapiesVTLPriced at $12.004.5 million4/17/2014BofA Merrill Lynch, Credit Suisse
Viventia Bio, Inc.VITATBDTBD0/0/0Leerink Securites, Cowen and Company, Guggenheim Securities
Voyager TherapeuticsVYGR$15.00-$17.005 million11/11/2015Cowen & Co., Piper Jaffray, Nomura, Wedbush PacGrow
vTv Therapeutics Inc.VTVT$15.00-$17.007.8 million 7/30/2015Piper Jaffray, Stifel
Wave Life Sciences PTE, Ltd.WVE$15.00-$17.006.375 million11/11/2015Jefferies, Leerink Partners
Xactly CorporationXTLY$10.00-$12.007.04 million6/26/2015J.P. Morgan, Deutsche Bank Securities, UBS Investment Bank
XBiotech, Inc.XBITPriced at $19.004 million4/15/2015WRHambrecht + Co.
Xenon PharmaceuticalsXENEPriced at $9.004 million11/5/2014Jefferies, Wells Fargo Securities
Zafgen, Inc.ZFGNPriced at $16.006 million6/19/2014Leerink Partners, Cowen and Company
Zoetis Inc.ZTSPriced at $26.0086.1 million2/1/2013J.P. Morgan, BofA Merrill Lynch, Morgan Stanley
Zosano Pharma CorporationZSANPriced at $11.004.5 million1/27/2015Ladenburg Thalmann, Roth Capital Partners
ZS Pharma Inc.,ZSPHPriced at $18.005.9 million6/18/2014J.P. Morgan, Credit Suisse
Zymeworks Inc.ZYME$13.00-$16.004.5 million4/28/2017Citigroup, Barclays, Wells Fargo Securities, Canaccord Genuity
Zynerba Pharmaceuticals, Inc.ZYNE$13.00-$15.003 million8/5/2015Jefferies, Piper Jaffray

IPO Boutique advisories are available with your choice of a monthly or annual payment.
To subscribe to IPO Boutique click:

© 2005 - 2017 IPO Boutique. All Rights Reserved